Sherri Hubby

Sherri Hubby has a diverse work experience in the pharmaceutical and healthcare industry, spanning over several decades. Their most recent role at Eiger BioPharmaceuticals, Inc. as a Senior Director of GCP QA involved ensuring the quality and compliance of clinical trials through audits and risk management. Prior to this, they held the position of Senior Director of R&D QA at Acadia Pharmaceuticals Inc., where they managed the quality assurance activities for research and development, including audits and quality system processes. At Myovant Sciences, as a Senior Director of GCP Quality Assurance, they oversaw the quality and compliance of clinical and non-clinical studies, as well as pharmacovigilance activities. Earlier in their career, they served as the Director of Vendor Compliance, R&D Quality, and Compliance at Gilead Sciences, where they implemented a vendor risk assessment program. Sherri also held the role of Senior Director of Quality Assurance, Risk, and Compliance at Premier Research, where they improved the quality management system and led various audits in GCP. Sherri's career began at the FDA as a Consumer Safety Officer, where they conducted inspections and investigations of FDA-regulated products. Overall, Sherri's extensive experience demonstrates their expertise in quality assurance, compliance, auditing, and risk management within the pharmaceutical and healthcare industry.

Sherri Hubby holds a Bachelor of Science (B.S.) degree in Marketing from Texas Woman's University. No specific information about the start or end year of their education at this institution is provided.